Tracking Trends in Secondary Stroke Prevention Strategies

Jody L. Carswell, Kemberley A. Beard, Michele M. Chevrette, Carol N. Pardue, David C Hess, Susan C. Fagan

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

BACKGROUND: Stroke is defined as a rapid onset of isolated neurologic dysfunction and is the leading cause of disability in adults, as well as the third-leading cause of death in the US. Nearly 600 000 cases of stroke are reported annually. OBJECTIVE: To quantify the impact of emerging evidence on the use of secondary stroke prevention strategies in patients discharged from a specialized stroke center in 2002 compared with those discharged in 2000. METHODS: Using a retrospective approach, data were collected on the first 100 patients cared for by the stroke service from July 1, 2000, to December 31, 2000. Using a prospective approach, the goal was to enroll 100 patients with a diagnosis of ischemic stroke and telephone the patients 1 and 3 months after discharge to determine patient adherence and persistence rate of medications. This is an interim report of the first 20 patients enrolled. RESULTS: Both studies resulted in populations of 55% women and 45% men. The most common risk factor was hypertension, with 59% on admission in 2000 and 75% in 2002. Use of antithrombotics (98% in 2000 to 100% in 2002) and antihypertensives (67% in 2000 to 90% in 2002) was high in both studies and not significantly different. The 2 most significant changes in prescribing were increased use of statins (13% in 2000 to 50% in 2002, p = 0.0007) and combination clopidogrel and aspirin use (0% in 2000 to 20% in 2002, p = 0.001). At 3 months, 66.7% of patients were on the same antithrombotic medication as at discharge. CONCLUSIONS: The dedicated stroke service was able to effectively translate emerging evidence and guidelines into practice and significantly change the use of prescribed medications for secondary stroke prevention.

Original languageEnglish (US)
Pages (from-to)215-219
Number of pages5
JournalAnnals of Pharmacotherapy
Volume38
Issue number2
DOIs
StatePublished - Feb 1 2004

Fingerprint

Secondary Prevention
Stroke
clopidogrel
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Medication Adherence
Patient Compliance
Neurologic Manifestations
Practice Guidelines
Telephone
Antihypertensive Agents
Aspirin
Cause of Death
Hypertension
Population

Keywords

  • Antihypertensives
  • Antithrombotics
  • Hypertension
  • Statins
  • Stroke prevention

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Carswell, J. L., Beard, K. A., Chevrette, M. M., Pardue, C. N., Hess, D. C., & Fagan, S. C. (2004). Tracking Trends in Secondary Stroke Prevention Strategies. Annals of Pharmacotherapy, 38(2), 215-219. https://doi.org/10.1345/aph.1D190

Tracking Trends in Secondary Stroke Prevention Strategies. / Carswell, Jody L.; Beard, Kemberley A.; Chevrette, Michele M.; Pardue, Carol N.; Hess, David C; Fagan, Susan C.

In: Annals of Pharmacotherapy, Vol. 38, No. 2, 01.02.2004, p. 215-219.

Research output: Contribution to journalArticle

Carswell, JL, Beard, KA, Chevrette, MM, Pardue, CN, Hess, DC & Fagan, SC 2004, 'Tracking Trends in Secondary Stroke Prevention Strategies', Annals of Pharmacotherapy, vol. 38, no. 2, pp. 215-219. https://doi.org/10.1345/aph.1D190
Carswell JL, Beard KA, Chevrette MM, Pardue CN, Hess DC, Fagan SC. Tracking Trends in Secondary Stroke Prevention Strategies. Annals of Pharmacotherapy. 2004 Feb 1;38(2):215-219. https://doi.org/10.1345/aph.1D190
Carswell, Jody L. ; Beard, Kemberley A. ; Chevrette, Michele M. ; Pardue, Carol N. ; Hess, David C ; Fagan, Susan C. / Tracking Trends in Secondary Stroke Prevention Strategies. In: Annals of Pharmacotherapy. 2004 ; Vol. 38, No. 2. pp. 215-219.
@article{f0081e0ae4024dc6ac1009fa6c3785ff,
title = "Tracking Trends in Secondary Stroke Prevention Strategies",
abstract = "BACKGROUND: Stroke is defined as a rapid onset of isolated neurologic dysfunction and is the leading cause of disability in adults, as well as the third-leading cause of death in the US. Nearly 600 000 cases of stroke are reported annually. OBJECTIVE: To quantify the impact of emerging evidence on the use of secondary stroke prevention strategies in patients discharged from a specialized stroke center in 2002 compared with those discharged in 2000. METHODS: Using a retrospective approach, data were collected on the first 100 patients cared for by the stroke service from July 1, 2000, to December 31, 2000. Using a prospective approach, the goal was to enroll 100 patients with a diagnosis of ischemic stroke and telephone the patients 1 and 3 months after discharge to determine patient adherence and persistence rate of medications. This is an interim report of the first 20 patients enrolled. RESULTS: Both studies resulted in populations of 55{\%} women and 45{\%} men. The most common risk factor was hypertension, with 59{\%} on admission in 2000 and 75{\%} in 2002. Use of antithrombotics (98{\%} in 2000 to 100{\%} in 2002) and antihypertensives (67{\%} in 2000 to 90{\%} in 2002) was high in both studies and not significantly different. The 2 most significant changes in prescribing were increased use of statins (13{\%} in 2000 to 50{\%} in 2002, p = 0.0007) and combination clopidogrel and aspirin use (0{\%} in 2000 to 20{\%} in 2002, p = 0.001). At 3 months, 66.7{\%} of patients were on the same antithrombotic medication as at discharge. CONCLUSIONS: The dedicated stroke service was able to effectively translate emerging evidence and guidelines into practice and significantly change the use of prescribed medications for secondary stroke prevention.",
keywords = "Antihypertensives, Antithrombotics, Hypertension, Statins, Stroke prevention",
author = "Carswell, {Jody L.} and Beard, {Kemberley A.} and Chevrette, {Michele M.} and Pardue, {Carol N.} and Hess, {David C} and Fagan, {Susan C.}",
year = "2004",
month = "2",
day = "1",
doi = "10.1345/aph.1D190",
language = "English (US)",
volume = "38",
pages = "215--219",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "2",

}

TY - JOUR

T1 - Tracking Trends in Secondary Stroke Prevention Strategies

AU - Carswell, Jody L.

AU - Beard, Kemberley A.

AU - Chevrette, Michele M.

AU - Pardue, Carol N.

AU - Hess, David C

AU - Fagan, Susan C.

PY - 2004/2/1

Y1 - 2004/2/1

N2 - BACKGROUND: Stroke is defined as a rapid onset of isolated neurologic dysfunction and is the leading cause of disability in adults, as well as the third-leading cause of death in the US. Nearly 600 000 cases of stroke are reported annually. OBJECTIVE: To quantify the impact of emerging evidence on the use of secondary stroke prevention strategies in patients discharged from a specialized stroke center in 2002 compared with those discharged in 2000. METHODS: Using a retrospective approach, data were collected on the first 100 patients cared for by the stroke service from July 1, 2000, to December 31, 2000. Using a prospective approach, the goal was to enroll 100 patients with a diagnosis of ischemic stroke and telephone the patients 1 and 3 months after discharge to determine patient adherence and persistence rate of medications. This is an interim report of the first 20 patients enrolled. RESULTS: Both studies resulted in populations of 55% women and 45% men. The most common risk factor was hypertension, with 59% on admission in 2000 and 75% in 2002. Use of antithrombotics (98% in 2000 to 100% in 2002) and antihypertensives (67% in 2000 to 90% in 2002) was high in both studies and not significantly different. The 2 most significant changes in prescribing were increased use of statins (13% in 2000 to 50% in 2002, p = 0.0007) and combination clopidogrel and aspirin use (0% in 2000 to 20% in 2002, p = 0.001). At 3 months, 66.7% of patients were on the same antithrombotic medication as at discharge. CONCLUSIONS: The dedicated stroke service was able to effectively translate emerging evidence and guidelines into practice and significantly change the use of prescribed medications for secondary stroke prevention.

AB - BACKGROUND: Stroke is defined as a rapid onset of isolated neurologic dysfunction and is the leading cause of disability in adults, as well as the third-leading cause of death in the US. Nearly 600 000 cases of stroke are reported annually. OBJECTIVE: To quantify the impact of emerging evidence on the use of secondary stroke prevention strategies in patients discharged from a specialized stroke center in 2002 compared with those discharged in 2000. METHODS: Using a retrospective approach, data were collected on the first 100 patients cared for by the stroke service from July 1, 2000, to December 31, 2000. Using a prospective approach, the goal was to enroll 100 patients with a diagnosis of ischemic stroke and telephone the patients 1 and 3 months after discharge to determine patient adherence and persistence rate of medications. This is an interim report of the first 20 patients enrolled. RESULTS: Both studies resulted in populations of 55% women and 45% men. The most common risk factor was hypertension, with 59% on admission in 2000 and 75% in 2002. Use of antithrombotics (98% in 2000 to 100% in 2002) and antihypertensives (67% in 2000 to 90% in 2002) was high in both studies and not significantly different. The 2 most significant changes in prescribing were increased use of statins (13% in 2000 to 50% in 2002, p = 0.0007) and combination clopidogrel and aspirin use (0% in 2000 to 20% in 2002, p = 0.001). At 3 months, 66.7% of patients were on the same antithrombotic medication as at discharge. CONCLUSIONS: The dedicated stroke service was able to effectively translate emerging evidence and guidelines into practice and significantly change the use of prescribed medications for secondary stroke prevention.

KW - Antihypertensives

KW - Antithrombotics

KW - Hypertension

KW - Statins

KW - Stroke prevention

UR - http://www.scopus.com/inward/record.url?scp=1642499305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642499305&partnerID=8YFLogxK

U2 - 10.1345/aph.1D190

DO - 10.1345/aph.1D190

M3 - Article

C2 - 14742753

AN - SCOPUS:1642499305

VL - 38

SP - 215

EP - 219

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 2

ER -